Journal of Cardiovascular Disease

Journal of Cardiovascular Disease Cardiology Journal of Cardiovascular Disease provides a global forum both for basic and clinical research on cardiovascular disease and stroke.
(264)

Lightning struck my heart ⚡❤️
08/15/2025

Lightning struck my heart ⚡❤️

❤️🧠 Published today in Circulation Research by Dr. Santulli and colleagues, the "NKT-SHERIFF" Study demonstrates for the...
05/23/2025

❤️🧠 Published today in Circulation Research by Dr. Santulli and colleagues, the "NKT-SHERIFF" Study demonstrates for the first time the mechanistic role of Natural Killer T Cells in heart failure, providing new insights into , , & in .
https://tinyurl.com/3et3y49c

BEST CLINICAL TRIALS IN A NUTSHELL:· SUMMIT assesses Tirzepatide in HFpEF and obesity, addressing two challenging cond...
11/19/2024

BEST CLINICAL TRIALS IN A NUTSHELL:

· SUMMIT assesses Tirzepatide in HFpEF and obesity, addressing two challenging conditions simultaneously through GLP-1 receptor agonist therapy.
· ENDEAVOR focuses on heart failure with preserved ejection fraction (HFpEF), addressing an area with limited treatment options.
· ALPACAR examines a new SIRNA treatment targeting Lp(a), a lipid marker with potential implications in dyslipidemia and inflammation.
· AI-ECHO explores the application of AI in echocardiography, potentially transforming diagnostic methods.
· VANISH2 compares catheter ablation and antiarrhythmic drugs for managing sustained ventricular tachycardia in ischemic heart disease patients, potentially altering treatment strategies.
· BRAIN AF investigates whether anticoagulation therapy can prevent cognitive decline in younger atrial fibrillation patients, which may influence stroke prevention approaches.
· ENBALV evaluates the use of Edoxaban post-valve replacement, potentially broadening NOAC use beyond traditional reliance on warfarin.
· NUDGE-FLU evaluates the cardiovascular benefits of flu vaccination, supported by a large sample size that could strengthen recommendations for heart disease patients.
· CLEAR SYNERGY (OASIS 9) studies colchicine and spironolactone in myocardial infarction patients, which could introduce novel treatment options.
· SARAH explores Sacubitril-Valsartan's efficacy beyond heart failure, particularly in reducing anthracycline-induced cardiotoxicity in cancer patients.
· BROAD evaluates the impact of blood pressure control on outcomes in diabetic patients, aiming to optimize management of coexisting conditions.
· REALIZE-K tests a new potassium chelator for heart failure patients, aiming to prevent discontinuation of RAAS inhibitors due to hyperkalemia.
· GLORIOUS investigates GLP-1 receptor agonists in new cardiovascular applications, given their expanding use and implications.

❤️ Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures
01/03/2024

❤️ Antithrombotic Therapy for Patients Undergoing Cardiac Electrophysiological and Interventional Procedures

01/02/2024

Your interpretation on this ECG?

12/31/2023

Merry Christmas!🎄❣️💚

🔴Just published: and rescue dysfunction via remodeling (JACC 2023) t.ly/cUa_
07/06/2023

🔴Just published: and rescue dysfunction via remodeling (JACC 2023)
t.ly/cUa_

Address

5140 Broadway
New York, NY
10032

Opening Hours

Monday 9am - 5pm
Tuesday 9am - 5pm
Wednesday 9am - 5pm
Thursday 9am - 5pm
Friday 9am - 5pm

Telephone

(347) 460-2620

Website

Alerts

Be the first to know and let us send you an email when Journal of Cardiovascular Disease posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Featured

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Category